Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
15m agoWest Red Lake Gold Mines Reports 2025 Results and Provides 2026 Production Guidance
15m agoIntegra Resources Announces First Quarter Production Results From The Florida Canyon Mine and Strengthened Balance Sheet
15m agoPan Global Resources Announces $7.2 Million Private Placement With Alpayana
16m agoLifezone Metals Announces Closing of $25 Million Registered Direct Offering
16m agoLithium Africa to Commence 2,000 m Drill Program at Adzopé and Provides Côte d'Ivoire Exploration Update
Artelo Biosciences Inc logo

Artelo Biosciences Inc

About

Artelo Biosciences Inc (NASDAQ:ARTL) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 20 2026
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
Mar 30 2026
Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Mar 27 2026
Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Mar 25 2026
Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments
Mar 18 2026
Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients

Financials

Revenue
$0
Market Cap
$5.32 M
EPS
-35.75

Community Chat

Ask AI

6ix6ixAIEvents